CARsgen showcases Satri-cel breakthroughs at ASCO 2025 and in The Lancet
June 02, 2025 | 16:29
Dual milestone affirms Satri-cel’s potential in solid tumour immunotherapy and advances CAR-T research.
CARsgen's Satri-cel Immunotherapy Makes ASCO Debut
May 23, 2025 | 08:00
The CAR-T cell therapy candidate garners attention for its potential in solid tumor treatment.
Mobile Version